ClearStar announced that it has secured two new customers with the contracts having an expected combined value of over $1 million annually commencing in 2019. The contracts, which are rolling contracts, are for the provision of Financial Institution Screening, representing the entry into a new market for ClearStar, and Medical Information Services (MIS) respectively. The company's contract for Financial Institution Screening has been awarded by a global professional services company that provides solutions to improve the operations of its Fortune 500 clients. ClearStar will provide screening for personnel placed with the customer's financial institution clients to ensure compliance with the US Federal Deposit Insurance Act (FDI Act), which governs the Federal Deposit Insurance Corporation and the banks insured by that organization, and the US Patriot Act. Under the new MIS contract, the company's ClearMD product will be used by a large consumer reporting agency, which is a new customer for ClearStar, to provide its clients with mobile-managed drug screening. ClearStar was selected as it is the only provider that offers paperless medical screening with a fully-customizable user platform across the three largest drug testing laboratories in the US, comprising over 9,500 medical test locations.